To determine mitochondrial (mt)DNA variants in AMD and age-matched normal retinas. METHODS. Total DNA was isolated from retinas (AMD, n ϭ 13; age-matched normal, n ϭ 13), choroid (AMD, n ϭ 3), and blood (AMD, n ϭ 138; normal, n ϭ 133). Long-extensionpolymerase chain reaction amplified the full-length (ϳ16.2 kb) mtDNA genome. Retinal mtDNA was sequenced for nucleotide variants and length heteroplasmy. Pyrosequencing was performed on heteroplasmic mtDNA. PCR amplification and enzyme digestions were used to analyze for nucleotide changes. RESULTS. Retinal mtDNA had a greater number of rearrangements and deletions than did blood mtDNA in normal samples (9.3 Ϯ 1.78 vs. 3 Ϯ 1.18, P ϭ 0.019), and AMD samples (14.33 Ϯ 1.96 vs. 5.2 Ϯ 0.80, P ϭ 0.0031. Five (55%) of 9 AMD patients had unreported SNPs, and 2 (16.6%) of 12 of the normal group did. The mtDNA coding region had 20 SNPs that produced amino acid changes. The noncoding MT-Dloop region had nucleotide heteroplasmy and length heteroplasmy. There were more SNPs per person in the AMD population than in the older (P ϭ 0.003) and younger (P ϭ 0.05) normal subjects. The C12557T (T-I) in the MT-ND5 gene was present in two AMD subjects (2/138) but was absent in the normal (0/133). Common mutations for Leber's hereditary optic neuropathy (LHON: G11778A; T14484C; and G3460A) were not present in AMD samples. CONCLUSIONS. AMD subjects have high levels of large mtDNA deletions/rearrangements in the retinas, unreported and amino acid-changing SNPs in the coding genome, and a greater number of SNPs per person in the noncoding MT-Dloop region. These mtDNA variants could diminish energy production efficiency, alter the mtDNA copy numbers and/or impact transcription in AMD retinas. (Invest Ophthalmol Vis Sci. 2010;51: 4289 -4297 The mtDNA genome comprises 16,569 nucleotides (nt) and encodes for 37 genes, 13 protein subunits essential for oxidative phosphorylation (OXPHOS), and 2 ribosomal (r)RNAs and 22 transfer (t)RNAs.
A ge-related macular degeneration (AMD) causes visual impairment in a large number of our elderly population. The dry or atrophic form of AMD (stage 4) has extensive loss of retinal pigment epithelial (RPE) cells and overlying retinal photoreceptors. Wet, or neovascular, AMD (stage 5) is characterized by severe vision loss due to choroidal neovascularization.
The mtDNA genome comprises 16,569 nucleotides (nt) and encodes for 37 genes, 13 protein subunits essential for oxidative phosphorylation (OXPHOS), and 2 ribosomal (r)RNAs and 22 transfer (t)RNAs.
1,2 mtDNA differs from human nuclear DNA in that it is circular and lacks 5Ј or 3Ј noncoding sequences and introns. 3 The 13 mtDNA encoded proteins include seven structural subunits of complex I, one subunit of complex III, three subunits of complex IV, and two subunits of complex V. Mutations and rearrangements within the mtDNA coding region are associated with diseases of the kidney, the skeletal and cardiac muscles, the brain, the eye, and the endocrine system. mtDNA has a noncoding 1121nt control region (MT-Dloop) that is critical for mtDNA replication and transcription. Mutations in the mtDNA control region have been described in patients with Alzheimer's disease and disorders associated with oxidative stress. 4 Photoreceptor cells contain numerous mitochondria responsible for generating sufficient energy for the metabolically active retina. The combination of high levels of reactive oxygen species (ROS) and poor repair mechanisms make the mtDNA very susceptible to oxidative damage, apoptosis, and cell death. The human aging retina has mitochondria with significant degeneration of cristae and disruption of membranes. 5 In a rat model of the degenerating retina, deletions in the mtDNA have been reported, 6 and in human RPE cultures, oxidative stress leads to preferential damage of mtDNA compared with nuclear DNA. 7 Although the involvement of mitochondria in metabolically active tissues has been discussed, few studies have been conducted to examine the mtDNA variations in retinal tissues from AMD patients and age-matched normal individuals.
In this study, AMD tissues had high levels of SNPs in the MT-Dloop region that affect replication and transcription. In addition, the retinal mtDNA had evidence of low copy heteroplasmy, which is usually associated with a disease state. Finally, there were numerous unreported and nonsynonymous SNPs associated with AMD. These variants could diminish the functional efficiency leading to insufficient energy for the highly metabolic retina.
pants, and the study was performed according to the tenets of the Declaration of Helsinki for research involving human subjects. A total of 271 individuals-133 normal subjects (average age 74 years, range 60 -93) and 138 AMD patients (average age 79 years, range 60 -95)-were studied.
Classification of AMD
The subjects underwent a complete dilated ophthalmic examination by board-certified ophthalmologists (DSB, ABN, MCK) including both slit lamp examination and an indirect ophthalmic examination with a 90-D lens or a fundus contact lens. Fundus photos, fluorescence, and/or indocyanine green angiography were performed. The photos and angiograms were read by masked graders who are board certified retina specialists.
Collection of Retinas
Globes from 13 normal (mean age, 77.38 years; range, 56 -97) and 13 AMD subjects (mean age 83.58 years, range, 69 -93; P ϭ 0.16) were collected from the National Disease Research Interchange (Philadelphia, PA) and/or the San Diego Eye Bank (Table 1 ). The diseased specimens had a clinical diagnosis and medical history of AMD that had significantly impaired vision. A board-certified ophthalmologist verified disease in the macular region by using the Minnesota Grading System of Eye Bank Eyes (Table 1) . 8 In this article, retina refers to the neural retina and choroid refers to the RPE and choroid. The sclera was removed and not analyzed. In three AMD individuals, we extracted DNA from both the retina and the choroid and/or the blood.
Extraction of Total DNA from Blood, Retinal, and Choroidal Tissues
We used a kit to isolate DNA from venous blood samples (10 mL) of the age-matched subjects (Puregene; Gentra, Minneapolis, MN). DNA was extracted from frozen retinal tissue by methods published elsewhere. 9 For the extraction of choroidal DNA, no centrifugation steps were performed because of the coprecipitation of DNA with melanin, a known inhibitor of PCR. 10 Instead, after the precipitation of DNA in ammonium acetate, the DNA precipitate was removed by hand and dip washed in 70% and 100% ethanol. The DNA was then dried and resuspended in Tris-EDTA (TE).
Long-Extension-Polymerase Chain Reaction (LX-PCR) Analyses
The total DNA isolated from normal and AMD retinas was used for LX-PCR amplification by modification of the method described by Atilano et al. 11 Briefly, LX-PCR was performed with 10 ng of DNA, a high-fidelity PCR system (FailSafe; Epicenter Biotechnologies, Madison, WI), and primers that specifically amplify 16,262 bp of the mtDNA.
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RFLP Analyses of mtDNA Variants
Restriction enzyme digestion of various PCR products (Table 2 ) was used to screen for the C12557T variant (BseYI) and the common LHON mutations: G11778A (LweI), G3460A (HgaI), and T14484C (BsaBI), according to the manufacturer's protocol (NEB, Ipswich, MA).
Mismatch-Specific Endonuclease Assay
PCR was performed on retina, choroid, and/or blood samples from three individuals using high fidelity DNA polymerases (PfuUltra II; 
Sequencing of the Entire mtDNA Genome
The retinal, choroidal, and blood DNA samples were subjected to PCR with various primers that spanned the entire mtDNA sequence. The PCR products were processed for sequencing by methods previously described.
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Pyrosequencing
This technology is a unique method of short-read DNA sequencing, allele quantification, and mutation/SNP analysis. A 400-bp sequence surrounding the heteroplasmy of interest was sent to the UCLA Genotyping and Sequencing Core for primer design. PCR was performed with a biotinylated forward primer (Invitrogen, Carlsbad, CA), and products were analyzed by the UCLA Genotyping and Sequencing Core.
Statistical Analyses
LX-PCR and semiquantitative PCR data were analyzed by unpaired t-test (two-tailed; GraphPad Software, Inc., San Diego, CA 
RESULTS
LX-PCR Analyses of Retinal Tissues and Blood mtDNA
The LX-PCR mtDNA bands (Ͻ16.2 and Ͼ1 kb) from different tissues were quantified and the mean values Ϯ SEM calculated ( Fig. 1 ). There was no significant difference between the number of LX-PCR mtDNA bands per individual in the normal and AMD retinas (9.30 Ϯ 1.78 vs. 14.3 Ϯ 1.96, P ϭ 0.088; Fig. 1A ) 1  0  0  1  Noncoding  Total  38  4  37  80 The letters a-f show which subjects had the nonsynonymous SNPs.
MT-TT
or the normal and AMD blood samples (3.0 Ϯ 1.18 vs. 5.2 Ϯ 0.80, P ϭ 0.16; Fig. 1B) . We then examined the number of LX-PCR mtDNA bands in the retinas (Fig. 1A) versus that in blood (Fig. 1B) and found significantly more rearrangements and mutations in both the normal (9.3 Ϯ 1.78 vs. 3.0 Ϯ 1.18, P ϭ 0.019) and AMD (14.33 Ϯ 1.96 vs. 5.2 Ϯ 0.80, P ϭ 0.0031) samples. Within the same AMD individual, the retina mtDNA showed a significantly higher number of small-sized bands than in the blood (11 Ϯ 1.0 vs. 0.5 Ϯ 0.5, P ϭ 0.011; Fig. 1C ), but the choroid values were similar (11 Ϯ 1.0 vs. 5.67 Ϯ 2.6, P ϭ 0.10). Choroidal mtDNA showed the most variability in the LX-PCR mtDNA profile (range, 1-10 small-sized bands), whereas retinas showed the least variability (range, 10 -14 bands). This suggests that choroidal mitochondrial mutations may not have a major role in the development of AMD.
Sequence Analyses of AMD Retina, Choroid, and Blood mtDNA
The entire mtDNA genomes from retinas, choroid, and/or blood of three AMD individuals were sequenced to determine nucleotide variations (Table 3 ). The nucleotide sequences of the retina, choroid, and blood from one individual were identical with each other but differed among AMD individuals. The noncoding MT-Dloop region contained 41.2% of the total number of SNPs found in the sequence (33/80). The A10420C Normal subjects (MT-tRNA(R)) has not been reported. Five of the SNPs in the coding regions of the mtDNA were associated with nonsynonymous amino acid changes (Table 3) :
A13780G(I-V, MT-ND5), and C14766T(T-I, MT-CYB).
The mtDNA from additional AMD (n ϭ 9) and normal (n ϭ 12) retinas were sequenced through the MT-ATP6 (nt8133-9698), MT-ND5 (nt12236-14233), and MT-CYB (nt14659-16126) genes. There were 7.0 SNPs per person in the AMD group and 6.5 per person in the normal group. When examined by decade, there were no significant differences between the AMD and normal populations (Table 4A ). There were seven unreported SNPs (Table 4B ) that had predicted amino acid changes. In the AMD population, 55% had an unreported SNPs, whereas the normal population had 16.6% (P ϭ 0.07). Table 4C lists 19 known SNPs that lead to amino acid changes (nonsynonymous) in the human retinal mtDNA. There were 2.44 nonsynonymous SNPs per person in the AMD population and 1.66 in the normal population.
The MT-Dloop region mtDNA was sequenced in AMD (n ϭ 10), age-matched normal subjects (n ϭ 8), and a younger subset of normal subjects (n ϭ 4; Table 5 ). There was a significantly greater number of SNPs per person in the AMD population (9.75 Ϯ 0.75) compared with either the older (5.90 Ϯ 0.77, P ϭ 0.003) or the younger (6.00 Ϯ 1.91, P ϭ 0.05) normal group. Subject AMD13 had the uncommon C12557T(T-I) variant in the retina, choroid, and blood (Fig. 2) . This SNP is uncommon and only reported as an unpublished polymorphism (www. MitoMap.org/ provided in the public domain by the Center for Molecular and Mitochondrial Medicine, University of California, Irvine). We then screened the blood mtDNA from 138 AMD subjects and 133 age-matched normal subjects (Fig. 2 ) and found this variant in an additional AMD patient (2/138) and in no normal subjects (0/133). This result suggests that the C12557T(T-I) variant found in our two AMD patients and located within the ND5 gene was unique and shows a strong association with AMD.
Length Heteroplasmy in the Control Region of Retinal mtDNA
The retinal MT-Dloop was sequenced to analyze the variations of the C insertions at different sites (303-309 and 568-573; Tables 6A, 6C ). The most common variation at site 303-309 was C7/T/C6. There were duplicate (C7/T/C6;C8/T/C6 and C8/T/ C6;C9/T/C6) and triplicate (C9/T/C6;C10/T/C6;C11/T/C6 and C8/T/C6;C9/T/C6;C10/T/C6) variations within single individuals in the AMD and normal groups.
At the 514-523 site, which has a polymorphic CA repeat, all but seven of the normal subjects had five CA repeats, and two had the 4CA repeat (Table 6B) . At the 568-573 site, all the normal (10/10) and most of the AMD (6/7) had an insertion of six C nucleotides. One AMD subject had a combination of C(8), C(9), and C(10) insertions (Table 6C) . At the 16,180-16,195 site, which is a complex repeat, 5 of 7 AMD and 6 of 12 normal subjects had the A4/C5/T/C4/AT variation (Table  6D ). There was a combination (heteroplasmy) of A2/C12/ AT;A2/C13/A;A2/C14/AT in one AMD subject and A3/C11/ AT;A3/C12/AT in one normal subject. One normal individual had a T nucleotide inserted to yield A4/C5/T/C2/TC/AT. One AMD subject had a triplicate A4/C9/AT;A4;C10/AT;A4/ C11/AT pattern.
Single-Nucleotide Heteroplasmy in the Control Region of Retinal mtDNA
Using conventional fluorescent (Sanger) sequencing, we observed heteroplasmy at two positions in the retinal mtDNA: T16092TC and T16093TC. A high ratio of single-nucleotide heteroplasmy, an uncommon feature of mtDNA, can be inherited or somatic. The 16,092 heteroplasmy change was found in the right eye retina, left eye retina, and right eye choroid of individual AMD4 (A4; Fig. 3 ) indicating that it is most likely inherited. Using both direct sequencing and pyrosequencing techniques, the peaks were quantified to show the C signal to be 65% and the T signal to be 35%. The second heteroplasmy T16093TC was found in a normal retina (N2) and showed a C signal of 73% and the T signal of 27%. Although sequencing techniques (Sanger) recognize high percentages of heteroplasmy change, they miss low-level nucleotide conversions that we suspect may be present in the retinal mtDNA. We used the surveyor nuclease kit to screen the MT-ATP6, MT-ND5, and MT-CYB genes for low level heteroplasmic changes. The MT-ND5 gene was difficult to amplify in a single PCR, and so it was divided into MT-ND5A (1275 nt) and MT-ND5B (1269 nt). Figure 4 shows a representative gel of MT-ND5B after the PCR product was treated with the nuclease assay. Ten bands were observed in the MT-ND5B gene. The MT-ND5A gene had six bands, the MT-ATP6 gene had four bands, and the MT-CYB gene had six bands. This finding suggests that in retinal mtDNA, the level of low copy heteroplasmy is significantly higher than that reported by sequence analyses.
Screen for the Common LHON Mutations
After PCR amplification and restriction digestion, the three most common LHON mutations, G3460A, G11778A, and T14484C, were screened from AMD and age-matched normal DNA samples (Table 7 ). All samples exhibited the wild-type alleles with no LHON mutation found in either the AMD or age-matched normal subjects.
DISCUSSION
In our study, the retinal mtDNA had 20 nonsynonymous SNPs that result in amino acid changes. Eight SNPs were found in the aged retinas that are unreported on MitoMap (www.mitomap. org). Five of the SNPs were found in AMD retina and four of those were changes that could lead to amino acid changes (Table 4A) . Further studies must be conducted to establish the significance of these new SNPs. If the amino acid substitution correlates with differences in OXPHOS efficiency, ROS formation and ATP production, then in a metabolically active tissue such as the retina, 12, 13 there would be a great amount of variability between individuals, with some aging retinas being more susceptible to oxidative damage and cell death. This notion is consistent with reports of increased mtDNA damage in the aging human retina 9 and in aging rodents that exhibit oxidative DNA damage and decreased levels of DNA repair enzymes. 14 The variations in mtDNA SNPs most likely are important in maintaining high bioenergetic capacity and visual function, with some substitution being more resistant to mtDNA damage than other SNP patterns. Surprisingly, the number of synonymous and nonsynonymous SNPs in the coding genes was similar in the AMD and age-matched normal retinas. We have previously reported that the noncoding mtDNA control region (MT-Dloop) has significantly greater numbers of SNPs per individual in the AMD retinas than in the age-matched normal retinas, 9 which suggests that abnormalities in the mitochondrial replication and transcription function play a role in retinal degeneration.
Sequence analysis of the entire mtDNA genome from human retinas, choroid, and/or blood from single individuals showed similar sequence patterns for each individual but significant variation among the different subjects. We used Sanger sequencing as a detection method; therefore, low level heteroplasmic changes were not scored and cannot be ruled out. The greatest number of SNPs (41.2%) was in the noncoding MT-Dloop, a region important in replication and transcription. The MT-Dloop is highly susceptible to nucleotide variations, and mutations within this region are found in patients with Alzheimer's disease and other disorders associated with oxidative stress. 4 The impact on replication and transcriptional efficiency caused by the MT-Dloop region hot spots is not understood at this time.
Recent studies show that AMD is associated with specific mtDNA SNPs that define Northern European haplogroups. 9, [15] [16] [17] We have found that the European haplogroups T, J, and U were associated with AMD patients, 9 whereas another study showed that the JT haplogroup defines SNPs in subjects with late AMD. 15 The haplogroup T-associated SNP A4917G is an independent predictor of AMD 16 and the J and U haplogroups are associated with clinically recognized AMD retinal lesions. 17 The nonsynonymous SNPs of different mtDNA haplogroups may lead to changes in OXPHOS efficiencies and increased ROS production that could increase susceptibility to oxidative stress and apoptosis. 18, 19 It is likely that some of these nonsynonymous SNPs can influence the mitochondrial energy production efficiency 4 by leading to a partially uncoupled OXPHOS, decreased ATP production per calories consumed, and increased heat production.
None of the AMD subjects had the three most common mtDNA mutations of LHON. This result was not unexpected, since the clinical onset and symptoms of the LHON and AMD patients are different. The milder LHON mutation on the specific J haplogroup background induces more severe disease, 20 and so perhaps on the J, U, or T haplogroup backgrounds, other SNPs act synergistically to create mitochondrial dysfunction and OXPHOS uncoupling in AMD subjects.
Length Heteroplasmy in the Control Region of Retinal mtDNA
In the retina mtDNA control regions, there were four sites of C insertions representing length heteroplasmy. One individual can have single, double, or triple C variation copies of the length heteroplasmy. These C variation sites have been reported in MitoMap gene sequences and include large stretches of Cs that may cause decreased efficiency of the control region. The MT-Dloop region has homoplasmic insertions that lead to a stretch of 6 Cs from nt 568 to 573. 21 This stretch of Cs may interact with a 7-bp stretch at region 302-308 to form a 270-nt duplication in the MT-Dloop. 21 Alternatively, there may be increased "slippage" due to loss of the T nucleotide anchor, resulting in large stretches of Cs that may cause erroneous base-pair matching and decreased replication efficiency.
As a result of a TϾC substitution at 16,189, there is a stretch of Cs along with either four or three adenines, the latter representing a single-bp deletion relative to the Cambridge reference sequence (CRS). 22 We found that in addition to 16189TϾC there was also a 16182AϾC substitution and a deleted A at position 16,183. This results in two adenines rather than the four adenines of the CRS. In subjects with the 16,189 variant, the length heteroplasmy may be created by replication slippage in the homopolymeric C stretch. Furthermore, the 16,189 position needs at least eight consecutive cytosines to show replication slippage while the position 310 needs a minimum of seven consecutive cytosines for slippage to occur. 23 The 16,189 changes are in the hypervariable region 1 (MT-HV1) of the mtDNA control region, and one can speculate that these changes could cause a decreased mitochondrial efficiency.
Heteroplasmy of Point Mutations in the Control Region of Retinal mtDNA
Using sequencing techniques, we identified two different SNPs with a high ratio of heteroplasmy in the retinal mtDNA. The 16092TϾTC heteroplasmy was found consistently in retina and choroid of the same individual. This heteroplasmic consistency has been reported between blood and buccal cells 24 and between blood and muscle. 25 In contrast, there are highly variable levels of heteroplasmy in skin hair roots. 24 A previous multiple-generation study showed that 16,092 had a C in the grandmother, a heteroplasmy of a ratio of ϳ0.7T:0.3C in the mother and one child, but a fixed 16092C for five other children. 26 The cause of the rapid change in this 16,092 position is not clear. The 16,092 site may represent a "hot spot" for nucleotide substitutions. The extremely rapid segregation of the 16,092 sequence within the generations is a possible mtDNA bottleneck that occurs in some families. Severe, deleterious mtDNA mutations are eliminated from the female germ line within a relatively short number of generations, whereas the more moderate, yet disease-producing, mtDNA mutations can undergo transmission for many generations. 27 The 16,092 SNP may be associated with a genetically undesirable condition so that rapid change is important, and finding the heteroplasmic condition captures a window of the transformation to the more stable homoplasmic condition. Control region heteroplasmy may impair mitochondrial copies and/or functional efficiency, thereby contributing to decreased energy production and cell death.
Direct (Sanger) sequencing of the mtDNA control regions is limited, in that heteroplasmic changes that have a high ratio above the threshold can be detected, whereas low-level heteroplasmy changes are not recognized. We analyzed for lowlevel heteroplasmy changes by using the nuclease assay (Surveyor Nuclease; Transgenomic) which detects heteroplasmy levels as low as 3%. 28 We identified low copy heteroplasmic sites in the MT-ATP6, MT-CYB, and MT-ND5 genes. The heteroplasmic substitutions are usually associated with disease, whereas the homoplasmic changes are usually polymorphisms that are not harmful. Future studies are needed to identify the functional consequences of the nonsynonymous SNPs, their length and heteroplasmy, and their higher levels in the MTDloop region. However, it is reasonable to speculate that high levels of somatic mtDNA damage can result in an age-related loss of mitochondrial function. 
